Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study
1
x
$
30.00
Paroxetine Treatment of Depression in Late Life
1
x
$
30.00
Complete Resolution of Catatonia Following a Single Intravenous Lorazepam Challenge Test: An Early Intervention in Psychosis Case Report
1
x
$
30.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 1
1
x
$
15.00
OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
1
x
$
0.00
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
1
x
$
30.00
Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity
1
x
$
30.00
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD
1
x
$
30.00
First Episode Psychosis in a Teen with Narcolepsy and Cataplexy
1
x
$
30.00
Psychopharmacology Bulletin VOL 49 No. 2, 2019 - Full Issue Stacked PDF
1
x
$
90.00
View Cart
Checkout
Home
paroxetine
You cannot add another "Paroxetine Treatment of Depression in Late Life" to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
$
30.00
Add to cart
Details
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
$
30.00
Add to cart
Details
Clinical Management of Perinatal Depression: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
$
30.00
Add to cart
Details
Paroxetine Treatment of Depression in Late Life
$
30.00
Add to cart
Details
Paroxetine Use in Medically Ill Patients
$
30.00
Add to cart
Details
Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
$
30.00
Add to cart
Details
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
$
30.00
Add to cart
Details
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Treatment of Panic Disorder: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
$
30.00
Add to cart
Details
Efficacy and Tolerability of Controlled-Release Paroxetine
$
30.00
Add to cart
Details
Negar Fani – Neuropsychological Functioning in Patients with Posttraumatic Stress Disorder Following Short-Term Paroxetine Treatment
$
30.00
Add to cart
Details
Page load link
Go to Top
